Skip Navigation

European Heart Journal 2001 22(5):363-369; doi:10.1053/euhj.2000.2462
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Puddu, P. E.
Right arrow Articles by Monti, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puddu, P. E.
Right arrow Articles by Monti, F
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Screening for drug-induced (acquired) long QT syndrome: is it time to apply new methods?

P. E. Puddu, A. Criniti and F Monti

Laboratory of Cardiovascular Phamacology, Institute of Cardiac Surgery, University of Rome ’La Sapienza‘ Rome, Italy

References

  1. Lande G, Kyndt F, Baró I. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J. 2001;22:410–422[Abstract/Free Full Text]
  2. Lehmann MH, Timothy KW, Frankovitch D. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotipically characterized long QT syndrome. J Am Coll Cardiol. 1997;29:93–99[Abstract]
  3. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782–784[Free Full Text]
  4. Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes (Editorial). Heart. 2000;84:235–237[Free Full Text]
  5. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:2334–2351[Free Full Text]
  6. Carlsson L, Abrahamsson C, Drews L, Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation. 1992;85:1491–1500[Abstract/Free Full Text]
  7. Shimizu W, Antzelevitch C. Effects of a K+channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long QT syndrome. Circulation. 2000;102:706–712[Abstract/Free Full Text]
  8. Crumb W, Cavero I. QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. Pharm Sci Technol Today. 1999;2:270–280[CrossRef][Medline]
  9. Criniti A, Picard S, Monti F. Cicletanine prevents the excitation-conduction blocks induced by terfenadine in ischemic myocardium. Eur J Pharmacol. 1999;382:197–205[CrossRef][ISI][Medline]
  10. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moyé L. Risk of developing life-threatening ventricular arrhythmias associated with terfenadine in comparison with overthe-counter antihistamines, ibuprofen and clemastine. Am J Cardiol. 1994;73:346–352[CrossRef][ISI][Medline]
  11. Puddu, PE, Book Reviews: the long QT syndrome, by Schwartz PJ, Clinical approaches to tachyarrhythmias, Camm, AJ, Armonk, Futura Publishing, 1997, G Ital Cardiol, 1998, 28, 329, 30
  12. Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE. The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol. 1996;54:237–249[CrossRef][ISI][Medline]
  13. Rouet R, Picard S, Criniti A. Effects of bimakalim on human cardiac action potentials: comparison with guinea pig and nicorandil and use-dependent study. J Cardiovasc Pharmacol. 1999;33:255–263[CrossRef][ISI][Medline]
  14. Puddu PE, Jouve R, Mariotti S. Evaluation of 10 QT prediction formulas in 881 middle-aged men from the Seven Countries Study: emphasis on the cubic root Fridericia's equation. J Electrocardiol. 1988;21:219–229[CrossRef][ISI][Medline]
  15. Schulze-Bahr E, Haverkamp W, Hordt M. Do mutations in cardiac ion channel genes predispose to drug-induced (acquired) long-QT syndrome? (Abstr). Circulation. 1997;96:I–211

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Puddu, P. E.
Right arrow Articles by Monti, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puddu, P. E.
Right arrow Articles by Monti, F
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?